Back to results
US 2023/0056577 A1Published application
Crispr-associated transposase systems and methods of use thereof
AssigneesThe Broad Institute, Inc., Massachusetts Institute of Technology
InventorsFeng Zhang, Jonathan Strecker, Alim Ladha
Life of this patent
Estimating the term…
Abstract
The present application provides systems, methods and compositions used for targeted gene modification, targeted insertion, perturbation of gene transcripts, nucleic acid editing. Novel nucleic acid targeting systems comprise components of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) systems and transposable elements.
Claims27
1-28. (canceled)
A delivery system configured to deliver one or more components of an engineered nucleic acid targeting system comprising:
- (a) one or more CRISPR-associated Tn7 transposase or Tn7-like transposase proteins that form a transposase;
- (b) a catalytically inactive Type V Cas protein capable of forming a complex with the transposase;
- (c) a guide molecule capable of forming a complex with the Type V Cas protein and directing sequence-specific binding of a guide-Cas protein complex to a target sequence of a target polynucleotide;
- and
- (d) a donor construct, comprising a heterologous donor polynucleotide sequence flanked by a first and second binding sequence capable of complexing the donor construct with the one or more Tn7 or Tn7-like transposase proteins.
2 more elements
Dependencies are inferred from the claim text.